Antoinette Moran
Marguerite & James Dugger Professor in Pediatrics, Division of Pediatric Endocrinology · University of Minnesota
Credentials: · · ·
History
- 1987–1990
- 1984–1987
Pediatrics
Research
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
New England Journal of Medicine · 2019 · 918 citations
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function
New England Journal of Medicine · 2009 · 862 citations
Insulin resistance during puberty: results from clamp studies in 357 children
Diabetes · 1999 · First of 7 authors · Corresponding · 688 citations
49 papers
46 papers
19 papers
18 papers · 3 as a fellow
18 papers
17 papers
17 papers
- CG
16 papers
Grants
- 2022–2027
Diabetes in African Youth: Improving Glucose Time-In-Range
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.8M · University of Minnesota
- 2004–2025
Pre-Faculty Research Training in Pediatric Endocrinology
National Institute of Diabetes and Digestive and Kidney Diseases · T32
Contact PI · $3.3M · University of Minnesota
- 2015–2022
The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic CF Patients
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $3.5M · University of Minnesota
- 2012–2020
Early Pathogenesis of Cystic Fibrosis Related Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases · R24
PI · $10.1M · University of Iowa
Clinical trials
- 2022–2027
- 2015–2022
The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis Patients
Principal investigator · Terminated · Phase 2, Phase 3
University of Minnesota
- 2003–2005
Insulin Glargine Vs Standard Insulin Therapy
Principal investigator · Completed · Phase 3
University of Minnesota
- 2001–2007
Diabetes Therapy to Improve BMI and Lung Function in CF
Principal investigator · Completed · Phase 3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)